StonvexLoading…
StonvexStonvexStonvexCore line items from CODX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $145.95K | $622.49K | $358.57K | $213.19K |
Operating Income | $-9.21M | $-50.17M | $-23.62M | $-16.61M |
Net Income | $-9.14M | $-46.90M | $-21.15M | $-7.73M |
EPS (Diluted) | $-4.06 | $-35.25 | $-0.62 | $-0.47 |
Total Assets | $21.50M | $24.74M | $44.74M | $46.47M |
Total Liabilities | $5.46M | $4.11M | $4.91M | $5.33M |
Cash & Equivalents | $8.23M | $11.88M | $11.44M | $11.12M |
Free Cash Flow OCF − CapEx | $-7.99M | $-29.84M | $-23.51M | $-17.53M |
Shares Outstanding | 3.60M | 2.10M | 48.14M | 36.18M |